01391nam a22004097a 4500 D0001C000194 DOH 20210505150229.0 210505b ||||| |||| 00| 0 eng d Safety and immunogenicity of SARS-CoV-2 recombinant protein vaccine formulations in healthy adults : interim results of a randomised, placebo-controlled, phase 1–2, dose-ranging study / Paul A Goepfert [and twenty two others] Lancet Infect Dis . 2021 Apr 19; S1473-3099 (21) 00147-X. doi: 10.1016/S1473-3099(21)00147-X COVID-19 Vaccines immunology Placebo Effect Goepfert, Paul A Fu, Bo Chabanon, Anne-Laure Bonaparte, Matthew I Davis, Matthew G Essink, Brandon J Frank, Ian Haney, Owen Janosczyk, Helene Keefer, Michael C Koutsoukos, Marguerite Kimmel, Murray A Masotti, Roger Savarino, Stephen J Schuerman, Lode Schwartz, Howard Sher, Lawrence D Smith, Jon Tavares-Da-Silva, Fernanda Gurunathan, Sanjay Granados, Carlos A Diaz de Bruyn, Guy JA 4417 4417 0 0 nlm 0 0 DOHCL DOHCL ElectronicRes 2021-05-05 0 COVID-19-000194 D0001C000194 2021-05-05 00:00:00 2021-05-05 JA